diclofenac has been researched along with Scleroderma, Systemic in 4 studies
Diclofenac: A non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt.
diclofenac : A monocarboxylic acid consisting of phenylacetic acid having a (2,6-dichlorophenyl)amino group at the 2-position.
Scleroderma, Systemic: A chronic multi-system disorder of CONNECTIVE TISSUE. It is characterized by SCLEROSIS in the SKIN, the LUNGS, the HEART, the GASTROINTESTINAL TRACT, the KIDNEYS, and the MUSCULOSKELETAL SYSTEM. Other important features include diseased small BLOOD VESSELS and AUTOANTIBODIES. The disorder is named for its most prominent feature (hard skin), and classified into subsets by the extent of skin thickening: LIMITED SCLERODERMA and DIFFUSE SCLERODERMA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We describe a patient with scleroderma who developed immune thrombocytopenia secondary to diclofenac on 2 occasions." | 7.68 | Diclofenac induced immune thrombocytopenia. ( Epstein, M; Stein, H; Vickars, L, 1990) |
| "We describe a patient with scleroderma who developed immune thrombocytopenia secondary to diclofenac on 2 occasions." | 3.68 | Diclofenac induced immune thrombocytopenia. ( Epstein, M; Stein, H; Vickars, L, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, BE | 1 |
| Jiang, X | 1 |
| Zhang, Q | 1 |
| Liang, Q | 1 |
| Qiu, ZL | 1 |
| Sun, XB | 1 |
| Yang, JJ | 1 |
| Chen, S | 1 |
| Yi, C | 1 |
| Chai, X | 1 |
| Liu, M | 1 |
| Yu, LF | 1 |
| Lu, W | 1 |
| Zhang, HK | 1 |
| Richard, V | 1 |
| Solans, V | 1 |
| Favre, J | 1 |
| Henry, JP | 1 |
| Lallemand, F | 1 |
| Thuillez, C | 1 |
| Marie, I | 1 |
| Epstein, M | 1 |
| Vickars, L | 1 |
| Stein, H | 1 |
| Kagan, A | 1 |
| Nissim, F | 1 |
| Green, L | 1 |
| Bar-Khayim, Y | 1 |
1 review available for diclofenac and Scleroderma, Systemic
| Article | Year |
|---|---|
Scleroderma renal crisis without hypertension.
Topics: Acute Kidney Injury; Diclofenac; Female; Humans; Middle Aged; Scleroderma, Systemic | 1989 |
3 other studies available for diclofenac and Scleroderma, Systemic
| Article | Year |
|---|---|
From a Designer Drug to the Discovery of Selective Cannabinoid Type 2 Receptor Agonists with Favorable Pharmacokinetic Profiles for the Treatment of Systemic Sclerosis.
Topics: Designer Drugs; Drug Discovery; Humans; Receptor, Cannabinoid, CB2; Scleroderma, Systemic; Structure | 2021 |
Role of endogenous endothelin in endothelial dysfunction in murine model of systemic sclerosis: tight skin mice 1.
Topics: Acetylcholine; Animals; Bosentan; Cyclooxygenase Inhibitors; Diclofenac; Disease Models, Animal; Dos | 2008 |
Diclofenac induced immune thrombocytopenia.
Topics: Diclofenac; Humans; Immune System Diseases; Male; Middle Aged; Platelet Count; Prednisone; Scleroder | 1990 |